[1]刘 宏,何明方,吴政俊.静脉溶栓前脑白质疏松程度与AIS患者术后HT及短期预后的关系[J].医学信息,2024,37(01):145-149.[doi:10.3969/j.issn.1006-1959.2024.01.025]
　LIU Hong,HE Ming-fang,WU Zheng-jun.Relationship Between the Degree of Leukoaraiosis Before Intravenous Thrombolysis and Postoperative HT, Short-term Prognosis in AIS Patients[J].Journal of Medical Information,2024,37(01):145-149.[doi:10.3969/j.issn.1006-1959.2024.01.025]
点击复制

静脉溶栓前脑白质疏松程度与AIS患者术后HT及短期预后的关系()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年01期
页码:
145-149
栏目:
论著
出版日期:
2024-01-01

文章信息/Info

Title:
Relationship Between the Degree of Leukoaraiosis Before Intravenous Thrombolysis and Postoperative HT, Short-term Prognosis in AIS Patients
文章编号:
1006-1959（2024）01-0145-05
作者:
刘 宏; 何明方; 吴政俊
（广元市中心医院脑血管病科，四川 广元 628000）
Author(s):
LIU Hong; HE Ming-fang; WU Zheng-jun
(Department of Cerebrovascular Diseases,Guangyuan Central Hospital,Guangyuan 628000,Sichuan,China)
关键词:
急性缺血性脑卒中; 溶栓; 出血转化; 预后; 脑白质疏松
Keywords:
Acute ischemic stroke; Thrombolysis; Hemorrhagic transformation; Prognosis; Leukoaraiosis
分类号:
R743
DOI:
10.3969/j.issn.1006-1959.2024.01.025
文献标志码:
A
摘要:
目的 探讨静脉溶栓前脑白质疏松程度对急性缺血性脑卒中（AIS）患者术后出血转化（HT）及短期预后的影响。方法 纳入2016年1月-2021年12月于我院行静脉溶栓治疗的AIS患者共288例，根据是否发生HT和预后情况分别分为伴HT组（242例）和无HT组（46例），预后良好组（166例）和预后不良组（122例），比较伴HT组和无HT组、预后良好组和预后不良组的临床特征，评价术后HT及90 d预后不良与静脉溶栓前脑白质疏松程度的关系。结果 伴HT组和无HT组中重度脑白质疏松患者比例、D-二聚体（D-D）水平及尿比重水平比较，差异有统计学意义（P＜0.05）；预后不良组和预后良好组年龄、基线美国国立卫生院神经功能缺损评分（NIHSS）、HT比例、基线随机血糖水平、国际标准化比值（INR）、急性卒中治疗Org10172试验（TOAST）分型、D-D，纤维蛋白原（FIB）、凝血酶原时间（PT）及尿糖阳性比例比较，差异有统计学意义（P＜0.05）；多因素Logistic回归分析显示，是否合并中重度脑白质疏松和D-D水平是AIS患者静脉溶栓术后HT的独立影响因素（P＜0.05）；基线NIHSS评分和白血胞计数（WBC）是AIS患者静脉溶栓术后90 d预后不良的独立影响因素（P＜0.05）。结论 AIS患者静脉溶栓术后是否HT与合并中重度脑白质疏松和D-D水平密切相关；另外，基线NIHSS评分高和高WBC计数的患者往往提示短期预后不良。
Abstract:
Objective To investigate the effect of leukoaraiosis before intravenous thrombolysis on postoperative hemorrhagic transformation (HT) and short-term prognosis in patients with acute ischemic stroke (AIS).Methods A total of 288 AIS patients who underwent intravenous thrombolysis in our hospital from January 2016 to December 2021 were included. According to the occurrence of HT and prognosis, they were divided into HT group (242 patients) and non-HT group (46 patients), good prognosis group (166 patients) and poor prognosis group (122 patients). The clinical characteristics of HT group and non-HT group, good prognosis group and poor prognosis group were compared, and the relationship between postoperative HT, poor prognosis at 90 days and the degree of leukoaraiosis before intravenous thrombolysis was evaluated.Results There were significant differences in the proportion of patients with moderate to severe leukoaraiosis, D-dimer (D-D) level and urine specific gravity level between the HT group and the non-HT group (P<0.05). There were statistically significant differences in age, baseline National Institutes of Health Stroke Scale (NIHSS) score, HT ratio, baseline random blood glucose level, international normalized ratio (INR), acute stroke treatment Org10172 test (TOAST) classification, D-D, fibrinogen (FIB), prothrombin time (PT) and urine glucose positive ratio between the poor prognosis group and the good prognosis group (P<0.05). Multivariate Logistic regression analysis showed that moderate to severe leukoaraiosis and D-D level were independent influencing factors of HT in AIS patients after intravenous thrombolysis (P<0.05). Baseline NIHSS score and white blood cell count (WBC) were independent influencing factors of poor prognosis at 90 days after intravenous thrombolysis in AIS patients (P<0.05).Conclusion Whether HT after intravenous thrombolysis in AIS patients is closely related to moderate to severe leukoaraiosis and D-D level. In addition, patients with high baseline NIHSS score and high WBC count often indicate poor short-term prognosis.

参考文献/References:

[1]李学慧,李晓波,姜超.中重度脑白质疏松对急性轻型缺血性卒中早期神经功能恶化的影响[J].医学研究生学报,2021,34(11):1163-1166.[2]吕亚星,姜超,梁朝辉,等.中、重度脑白质疏松与急性缺血性脑卒中患者静脉溶栓出血转化及预后的关系[J].中华神经医学杂志,2020,19(9):873-881.[3]Nakada T,Kwee IL.Fluid Dynamics Inside the Brain Barrier: Current Concept of Interstitial Flow, Glymphatic Flow, and Cerebrospinal Fluid Circulation in the Brain[J].Neuroscientist,2019,25(2):155-166.[4]Georgakis MK,Duering M,Wardlaw JM,et al.WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis[J].Neurology,2019,92(12):e1298-e1308.[5]Nagaraja N,Tasneem N,Shaban A,et al.Cerebral microbleeds are an independent predictor of hemorrhagic transformation following intravenous alteplase administration in acute ischemic stroke[J].J Stroke Cerebrovasc Dis,2018,27(5):1403-1414[6]Makkinejad N,Tamhane AA,Leurgans SE,et al.Neuropathologic and Cognitive Correlates of Enlarged Perivascular Spaces in a Community-Based Cohort of Older Adults[J].Stroke,2020,51(9):2825-2833.[7]李江浩,陈雪林,盛罗平,等.脑白质疏松与急性前循环大血管闭塞性脑卒中病人血管内治疗预后的关系[J].中西医结合心脑血管病杂志,2022,20(6):1110-1113.[8]Wardlaw JM,Smith C,Dichgans M.Small vessel disease: mechanisms and clinical implications[J].Lancet Neurol,2019,18(7):684-696.[9]Liu Y,Zhang M,Chen Y,et al.The degree of leukoaraiosis predicts clinical outcomes and prognosis in patients with middle cerebral artery occlusion after intravenous thrombolysis[J].Brain Res,2018,16(8):28-33.[10]Levine DA,Galecki A,Kabeto M,et al.Mild cognitive impairment and receipt of procedures for acute ischemic stroke in older adults[J].J Stroke Cerebrovasc Dis,2020,29(10):105083.[11]Chen Y,Yan S,Xu M,et al.More extensive white matter hyperintensity is linked with higher risk of remote intracerebral hemorrhage after intravenous thrombolysis[J].Eur J Neurol,2018,25(2):380-e15.[12]McGrory S,Ballerini L,Doubal FN,et al.Retinal microvasculature and cerebral small vessel disease in the Lothian Birth Cohort 1936 and Mild Stroke Study[J].Sci Rep,2019,9(1):6320-6327.[13]Mikati AG,Mandelbaum M,Sapnar S,et al.Impact of leukoaraiosis severity on the association of time to successful reperfusion with 90-day functional outcome after large vessel occlusion stroke[J].Transl Stroke Res,2019,11(1):39-49.[14]Li Y,Li M,Yang L,et al.The relationship between blood-brain barrier permeability and enlarged perivascular spaces:a cross-sectional study[J].Clin Interv Aging,2019,14(6):871-878.[15]Yang CM,Hung CL,Su HC,et al.Leukoaraiosis and risk of intracranial hemorrhage and outcome after stroke thrombolysis[J].PLoS One,2018,13(5):e0196505.[16]McHutchison CA,Chappell FM,Makin S,et al.Stability of Estimated Premorbid Cognitive Ability over Time after Minor Stroke and Its Relationship with Post-Stroke Cognitive Ability[J].Brain Sci,2019,9(5):117-122.[17]Wardlaw JM,Benveniste H,Nedergaard M,et al.Perivascular spaces in the brain:anatomy,physiology and pathology[J].Nat Rev Neurol,2020,16(3):137-153.[18]Chodnicki KD,Pulido JS,Hodge DO,et al.Stroke risk before and after central retinal artery occlusion in a US cohort[J].Mayo Clin Proc,2019,94(2):236-241.[19]Khan M,Heiser H,Bernicchi N,et al.Leukoaraiosis predicts short-term cognitive but not motor recovery in ischemic stroke patients during rehabilitation[J].J Stroke Cerebrovasc Dis,2019,28(6):1597-1603.[20]Powers WJ,Rabinstein AA,Ackerson T,et al.2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2018,49(3):e46-e110.

相似文献/References:

[1]宋俊燕,张 毅.重组人尿激酶原在急性ST段抬高型心肌梗死中的 疗效及并发症分析[J].医学信息,2018,31(11):133.[doi:10.3969/j.issn.1006-1959.2018.11.042]
　SONG Jun-yan,ZHANG Yi.Therapeutic Efficacy and Complications of Recombinant Human Pro-urokinase in Acute ST-elevation Myocardial Infarction[J].Journal of Medical Information,2018,31(01):133.[doi:10.3969/j.issn.1006-1959.2018.11.042]
[2]王跃慧.急性缺血性脑卒中的药物治疗[J].医学信息,2022,35(11):44.[doi:10.3969/j.issn.1006-1959.2022.11.013]
　WANG Yue-hui.Drug Treatment of Acute Ischemic Stroke[J].Journal of Medical Information,2022,35(01):44.[doi:10.3969/j.issn.1006-1959.2022.11.013]
[3]王珊珊.国内丁苯肽治疗急性缺血性脑卒中机制的应用研究[J].医学信息,2019,32(09):58.[doi:10.3969/j.issn.1006-1959.2019.09.019]
　WANG Shan-shan.Study on the Application of Domestic Butyl Phenyl Peptide in the Treatment of Acute Ischemic Stroke[J].Journal of Medical Information,2019,32(01):58.[doi:10.3969/j.issn.1006-1959.2019.09.019]
[4]郑钰蓉,殷 梅,罗 悯.急性缺血性脑卒中伴发脑心综合征的临床研究[J].医学信息,2022,35(17):156.[doi:10.3969/j.issn.1006-1959.2022.17.043]
　ZHENG Yu-rong,YIN Mei,LUO Min.Clinical Study of Acute Ischemic Stroke with Cerebrocardiac Syndrome[J].Journal of Medical Information,2022,35(01):156.[doi:10.3969/j.issn.1006-1959.2022.17.043]
[5]杨涌涛,金 戈,李 鑫,等.脑梗死静脉溶栓后出血转化与脂质代谢异常的 相关性研究[J].医学信息,2019,32(14):75.[doi:10.3969/j.issn.1006-1959.2019.14.024]
　YANG Yong-tao,JIN Ge,LI Xin,et al.Correlation between Hemorrhagic Transformation and Abnormal Lipid Metabolism after Venous Thrombolysis in Patients with Cerebral Infarction[J].Journal of Medical Information,2019,32(01):75.[doi:10.3969/j.issn.1006-1959.2019.14.024]
[6]姜 博,刘 艳.FPG和HbA1c对急性脑梗死合并2型糖尿病患者静脉溶栓效果的影响[J].医学信息,2020,33(08):118.[doi:10.3969/j.issn.1006-1959.2020.08.037]
　JIANG Bo,LIU Yan.Effects of FPG and HbA1c on the Efficacy of Intravenous Thrombolysis in Patients with Acute Cerebral Infarction and Type 2 Diabetes[J].Journal of Medical Information,2020,33(01):118.[doi:10.3969/j.issn.1006-1959.2020.08.037]
[7]黄冬琴,吴 蔓.不同剂量尿激酶经导管溶栓治疗下肢深静脉血栓形成的疗效[J].医学信息,2020,33(10):122.[doi:10.3969/j.issn.1006-1959.2020.10.034]
　HUANG Dong-qin,WU Man.Therapeutic Effect of Different Doses of Urokinase via Catheter Thrombolysis on Lower Limb Deep Vein Thrombosis[J].Journal of Medical Information,2020,33(01):122.[doi:10.3969/j.issn.1006-1959.2020.10.034]
[8]宋贵军.急性缺血性脑卒中静脉溶栓治疗[J].医学信息,2020,33(17):47.[doi:10.3969/j.issn.1006-1959.2020.17.014]
　SONG Gui-jun.Intravenous Thrombolytic Therapy for Acute Ischemic Stroke[J].Journal of Medical Information,2020,33(01):47.[doi:10.3969/j.issn.1006-1959.2020.17.014]
[9]褚春沐.血浆纤维蛋白原和D-二聚体在急性缺血性脑卒中治疗中的应用价值[J].医学信息,2022,35(21):101.[doi:10.3969/j.issn.1006-1959.2022.21.024]
　CHU Chun-mu.The Application Value of Plasma Fibrinogen and D-dimer in the Treatment of Acute Ischemic Stroke[J].Journal of Medical Information,2022,35(01):101.[doi:10.3969/j.issn.1006-1959.2022.21.024]
[10]罗贤云.阿托伐他汀联合双抗治疗对急性缺血性脑卒中患者血脂、神经功能及预后的影响[J].医学信息,2022,35(23):133.[doi:10.3969/j.issn.1006-1959.2022.23.027]
　LUO Xian-yun.Effect of Atorvastatin Combined with Double Antibody Therapy on Blood Lipid, Neurological Function and Prognosis in Patients with Acute Ischemic Stroke[J].Journal of Medical Information,2022,35(01):133.[doi:10.3969/j.issn.1006-1959.2022.23.027]

更新日期/Last Update: 1900-01-01